TheProfitWatch

VYNE - VYNE Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.35 0.01 (3.74%) --- --- 0.0 (-0.45%) 0.0 (0.17%) 0.02 (4.65%) 0.0 (0.46%) 0.0 (-0.8%)

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.13
Diluted EPS:
-0.13
Basic P/E:
-2.7531
Diluted P/E:
-2.7531
RSI(14) 1m:
59.57
VWAP:
0.36
RVol:

Events

Period Kind Movement Occurred At

Related News